2008-05-08 09:31 ET - News Release
Mr. Renaud Beauchesne reports
RICHARD BORDELEAU TO JOIN ADVITECH'S BOARD OF DIRECTORS
The management of Advitech Inc. will propose today at the annual general meeting of the company the addition of Richard Bordeleau as candidate to Advitech's board of directors, thus increasing to six the number of directors from five, as stated in the proxy circular. The annual general meeting will take place at 5 p.m. Eastern Time at the Germain Des Pres Hotel in Quebec City (Rochette Nadeau Room).
Mr. Bordeleau is currently the executive vice-president of BioCad Medical, a high-tech company specialized in computer-aided design and manufacturing of dental and medical prosthesis, located in Quebec City. Prior to joining BioCad, from 2001 to September, 2007, he was president of Atrium Innovations' health and nutrition division after holding the position of vice-president of that company for one year in 2000. Atrium Innovations is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. Previously, he occupied various positions on the management team of AEterna Zentaris, a biopharmaceutical company where he started in February, 1994, as director of marketing and became its senior vice-president, corporate development, from 1998 until 2000. Throughout his career, he focused on developing strong organic and external growth through international development, partnerships and acquisitions.
"The addition of Mr. Bordeleau will enhance our board of directors, and help the management of the company to better identify market opportunities and responses to strategic challenges at Advitech. Mr. Bordeleau will bring his solid experience in the development and expansion of companies to Advitech's board and management," stated Renaud Beauchesne, president and chief executive officer of Advitech.
